Human medicines European public assessment report (EPAR): Abiraterone Accord, abiraterone, Date of authorisation: 26/04/2021, Revision: 4, Status: Authorised

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – April 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 1 April 2025, 10:00 (CEST) to 1 April 2025, 12:00 (CEST)

Minutes - Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) (April 2025)

Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Arsenic trioxide Mylan, arsenic trioxide, Date of authorisation: 01/04/2020, Revision: 6, Status: Withdrawn

Agenda of the PRAC meeting 5-8 May 2025

Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 2 - track changes

Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 2

Human medicines European public assessment report (EPAR): Trelegy Ellipta, fluticasone furoate,umeclidinium,vilanterol, Date of authorisation: 15/11/2017, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Ketoconazole Esteve (previously Ketoconazole HRA), ketoconazole, Date of authorisation: 18/11/2014, Revision: 12, Status: Authorised